Praxis Precision Medicines Inc
Statements
Cash Flow
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | -65.4% | +0.9% | -4.5% | -3,397.2% | – | +0.0% | -2,102.1% | – | +47.4% | +39.3% | -15.4% | – | |
| – | -0.6% | +152.8% | -59.4% | +111.5% | -31.0% | +2.5% | -11.6% | -4.2% | +33.4% | +72.2% | -33.9% | – | |
| – | – | – | -58.9% | -405.5% | – | – | +7.2% | -76.8% | -3.6% | -586.3% | – | – | |
| – | – | -100.0% | – | – | – | – | +87.5% | -100.0% | – | – | +295.2% | – | |
| – | – | +182,340.0% | +114.8% | – | -122.0% | +367.7% | – | +181.7% | -751.4% | +4.8% | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +400.0% | +2,640.0% | +0.0% | -99.3% | – | – | – | – | – | – | – | – | |
| – | – | +4,621.5% | +18.6% | -99.3% | +7,822.5% | -52.6% | -46.9% | -77.5% | +9,430.1% | -0.7% | -99.4% | – | |
| – | – | – | -109.7% | – | +98.8% | -206.6% | – | – | – | -13.9% | -135.3% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.